VRDN Jul 2024 17.500 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 09:30AM EDT. Market open.
| Previous close | 0.1300 |
| Open | 0.7500 |
| Bid | 0.0000 |
| Ask | 4.4000 |
| Strike | 17.50 |
| Expiry date | 2024-07-19 |
| Day's range | 0.7500 - 0.7500 |
| Contract range | N/A |
| Volume | |
| Open interest | 50 |
Business WireViridian Therapeutics to Participate in Upcoming May Investor Conferences
WALTHAM, Mass., May 10, 2024--Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced that senior management will participate in the following upcoming investor conferences in May:
Simply Wall St.Viridian Therapeutics First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
Viridian Therapeutics ( NASDAQ:VRDN ) First Quarter 2024 Results Key Financial Results Net loss: US$48.5m (loss...
- GuruFocus.com
Viridian Therapeutics Inc (VRDN) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
Discover key insights from VRDN's Q1 2024 earnings, including trial successes, financial stability, and future regulatory plans.
© 2024 Yahoo. All rights reserved.